A biotech founder tells you their Phase 2 trial data looks amazing. They're raising $200M tomorrow. What's the one question you'd ask before letting them into the room with investors?
Who outside your company has replicated your results, and can we call them tomorrow?
I raised $700 million from the most sophisticated investors in America — the Waltons, Rupert Murdoch, John Doerr — and not one of them asked to see our technology work in a real lab with real blood samples. We controlled every demonstration...